Free Trial

California Public Employees Retirement System Cuts Holdings in Balchem Co. (NASDAQ:BCPC)

Balchem logo with Basic Materials background
Remove Ads

California Public Employees Retirement System reduced its stake in shares of Balchem Co. (NASDAQ:BCPC - Free Report) by 2.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 103,171 shares of the basic materials company's stock after selling 2,529 shares during the quarter. California Public Employees Retirement System owned 0.32% of Balchem worth $16,816,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds also recently added to or reduced their stakes in the stock. Westside Investment Management Inc. purchased a new position in Balchem in the 3rd quarter valued at approximately $27,000. R Squared Ltd acquired a new stake in Balchem in the fourth quarter valued at $29,000. Wilmington Savings Fund Society FSB purchased a new position in shares of Balchem in the third quarter valued at $35,000. Venturi Wealth Management LLC acquired a new position in shares of Balchem during the 4th quarter worth $95,000. Finally, Smartleaf Asset Management LLC boosted its position in shares of Balchem by 230.8% in the 4th quarter. Smartleaf Asset Management LLC now owns 645 shares of the basic materials company's stock worth $106,000 after buying an additional 450 shares in the last quarter. 87.91% of the stock is owned by hedge funds and other institutional investors.

Balchem Trading Up 6.1 %

Shares of Balchem stock traded up $9.14 during mid-day trading on Wednesday, hitting $159.64. 276,208 shares of the stock were exchanged, compared to its average volume of 126,604. The company has a 50-day simple moving average of $164.93 and a 200 day simple moving average of $168.32. The company has a current ratio of 1.99, a quick ratio of 1.16 and a debt-to-equity ratio of 0.19. The stock has a market capitalization of $5.19 billion, a price-to-earnings ratio of 40.62, a price-to-earnings-growth ratio of 4.41 and a beta of 0.75. Balchem Co. has a twelve month low of $137.69 and a twelve month high of $186.03.

Remove Ads

Balchem (NASDAQ:BCPC - Get Free Report) last released its earnings results on Friday, February 21st. The basic materials company reported $1.03 EPS for the quarter, missing the consensus estimate of $1.11 by ($0.08). Balchem had a return on equity of 11.37% and a net margin of 13.47%. The firm had revenue of $240.00 million during the quarter, compared to analysts' expectations of $239.96 million. Research analysts forecast that Balchem Co. will post 4.64 EPS for the current year.

Wall Street Analysts Forecast Growth

BCPC has been the subject of several recent research reports. Sidoti upgraded shares of Balchem to a "hold" rating in a report on Tuesday, February 25th. StockNews.com cut shares of Balchem from a "buy" rating to a "hold" rating in a research note on Tuesday, February 25th. Finally, HC Wainwright reaffirmed a "buy" rating and issued a $190.00 target price on shares of Balchem in a research note on Monday, February 24th.

View Our Latest Stock Analysis on BCPC

Balchem Company Profile

(Free Report)

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.

Featured Articles

Institutional Ownership by Quarter for Balchem (NASDAQ:BCPC)

Should You Invest $1,000 in Balchem Right Now?

Before you consider Balchem, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Balchem wasn't on the list.

While Balchem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

These 3 Dividend Stocks Might Be the Safest Bet Right Now
5 International Stocks to Escape U.S. Market Volatility
MicroStrategy’s Bold Bitcoin Bet: Genius Move or Dangerous Gamble?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads